BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1404171)

  • 1. Systemic lupus erythematosus presenting with myelofibrosis.
    Foley-Nolan D; Martin MF; Rowbotham D; McVerry A; Gooi HC
    J Rheumatol; 1992 Aug; 19(8):1303-4. PubMed ID: 1404171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus.
    Paquette RL; Meshkinpour A; Rosen PJ
    Medicine (Baltimore); 1994 May; 73(3):145-52. PubMed ID: 8190037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus presenting as myelofibrosis.
    Konstantopoulos K; Terpos E; Prinolakis H; Kanta A; Variami E; Kanellopoulou G; Vaiopoulos G; Floros A; Androulaki A; Meletis J
    Haematologia (Budap); 1998; 29(2):153-6. PubMed ID: 9728808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelofibrosis secondary to SLE and its reversal on steroid therapy.
    Agarwal BR; Bhalla K; Dalvi R; Currimbhoy ZE; Mehta KP
    Indian Pediatr; 1995 Nov; 32(11):1207-10. PubMed ID: 8772871
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic lupus erythematosus presenting with pancytopenia due to bone marrow myelofibrosis in a 22-year-old male.
    Aziz AR; Mohammadian Y; Ruby C; Momin Z; Kumar A; Griciene P; Gintautas J
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):467-9; discussion 469-70. PubMed ID: 16163223
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.
    Üsküdar Cansu D; Üsküdar Teke H; Işiksoy S; Korkmaz C
    Int J Rheum Dis; 2018 May; 21(5):1049-1059. PubMed ID: 29671953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy.
    Inoue Y; Matsubara A; Okuya S; Okafuji K; Kaku K; Kaneko T
    Acta Haematol; 1992; 88(1):32-6. PubMed ID: 1414159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenia associated with myelofibrosis in systemic lupus erythematosus.
    Borba EF; Pereira RM; Velloso ED; Pereira IA; Goncalves CR; Yoshinari NH
    Acta Haematol; 1993; 89(2):82-5. PubMed ID: 8503249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
    Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
    Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune myelofibrosis and systemic lupus erythematosus in a middle-aged male presenting only with severe anemia: a case report.
    Pundole X; Konoplev S; Oo TH; Lu H
    Medicine (Baltimore); 2015 May; 94(19):e741. PubMed ID: 25984660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus with polyarthralgias due to myelofibrosis in a 49-year-old female.
    Fechner A; Hummel V; Moustarhfir M; Manelfe J; Schouman-Claeys E; Dallaudière B
    Diagn Interv Imaging; 2014 Mar; 95(3):323-4. PubMed ID: 24440106
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case report.
    Wibowo T; Kawada S; Ishida Y; Yoshimine Y; Ishikawa N; Kawamoto K; Kato Y; Higa S; Ogata A; Maeda K
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):28-33. PubMed ID: 33086960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematological presentation of systemic lupus erythematosus.
    Sarkar RN; Banerjee S; Dey S; Saha A; Bhattacharjee P; Banerjee TK; Sinha PK; Chakraborty A
    J Assoc Physicians India; 2009 Nov; 57():767-8. PubMed ID: 20329445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P
    Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral periorbital edema in systemic lupus erythematosus.
    Norden D; Weinberg J; Schumacher HR; Keenan G; Freundlich B
    J Rheumatol; 1993 Dec; 20(12):2158-60. PubMed ID: 8014949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
    Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
    Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of early secondary myelofibrosis in SLE with IVIG.
    Aharon A; Levy Y; Bar-Dayan Y; Afek A; Zandman-Goddard G; Skurnik Y; Fabrrizzi F; Shoenfeld Y
    Lupus; 1997; 6(4):408-11. PubMed ID: 9175029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.
    Ungprasert P; Chowdhary VR; Davis MD; Makol A
    Lupus; 2016 Apr; 25(4):427-30. PubMed ID: 26537421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelofibrosis in systemic lupus erythematosus.
    Kiss E; Gál I; Simkovics E; Kiss A; Bányai A; Szakáll S; Szegedi G
    Leuk Lymphoma; 2000 Nov; 39(5-6):661-5. PubMed ID: 11342352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.